# Can the Health Benefits of a Walking-based Exercise Programme be Enhanced by Co-ingestion of a Lipid-lowering Drug?

> **NCT03809793** · NA · COMPLETED · sponsor: **Liverpool John Moores University** · enrollment: 15 (actual)

## Conditions studied

- Pre-diabetes

## Interventions

- **OTHER:** Exercise Program
- **DIAGNOSTIC_TEST:** DXA
- **DIAGNOSTIC_TEST:** MRI
- **DIAGNOSTIC_TEST:** Hyperinsulinaemic Euglycaemic Clamp
- **DIAGNOSTIC_TEST:** VO2 Max
- **DIAGNOSTIC_TEST:** Continuous Glucose Monitor
- **PROCEDURE:** Muscle Biopsies
- **DRUG:** Acipimox 250 MG

## Key facts

- **NCT ID:** NCT03809793
- **Lead sponsor:** Liverpool John Moores University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-06
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-01-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809793, "Can the Health Benefits of a Walking-based Exercise Programme be Enhanced by Co-ingestion of a Lipid-lowering Drug?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03809793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*